BIOMARKERS FOR DIABETES COMPLICATIONS: THE RESULTS OF SEVERAL CLINICAL STUDIES

被引：9

作者：

Aslan, Diler ^{[1
]}

机构：

[1] Pamukkale Univ, Sch Med, Dept Med Biochem, Denizli, Turkey

来源：

JOURNAL OF MEDICAL BIOCHEMISTRY | 2011年 / 30卷 / 03期

关键词：

diabetes; biomarkers; clinical studies; HEPATOCYTE GROWTH-FACTOR; URINARY BIOMARKERS; GENE POLYMORPHISMS; OXIDATIVE STRESS; DISEASE; ASSOCIATION; MELLITUS; RISK; NEPHROPATHY; MORTALITY;

D O I：

10.2478/v10011-011-0024-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Diabetes is a common metabolic disorder. Its microvascular and macrovascular complications contribute to death, disabilities, and reduction in life expectancy in diabetes. It is a costly disease, and affects not only the patient and family, but also the public health, communities and society. It takes an increasing proportion of the national health care expenditure. The prevention of the development of diabetes and its complications is a major concern. Biomarkers have been investigated for understanding the mechanisms of the development and progression of diabetic complications. In this paper, the biomarkers which are recommended in the clinical practice and laboratory medicine guidelines, and which have been investigated for prediction or diagnosis of diabetes complications, have been reviewed. The results of several clinical studies will be summarized.

引用

页码：207 / 212

页数：6

共 61 条

[11] Oxidative stress: A cause and therapeutic target of diabetic complications [J].

Araki, Eiichi ;

Nishikawa, Takeshi .

JOURNAL OF DIABETES INVESTIGATION, 2010, 1 (03) :90-96

[12] Metabolomics Applied to Diabetes Research Moving From Information to Knowledge [J].

Bain, James R. ;

Stevens, Robert D. ;

Wenner, Brett R. ;

Ilkayeva, Olga ;

Muoio, Deborah M. ;

Newgard, Christopher B. .

DIABETES, 2009, 58 (11) :2429-2443

[13] Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy [J].

Balasubbu, Suganthalakshmi ;

Sundaresan, Periasamy ;

Rajendran, Anand ;

Ramasamy, Kim ;

Govindarajan, Gowthaman ;

Perumalsamy, Namperumalsamy ;

Hejtmancik, J. Fielding .

BMC MEDICAL GENETICS, 2010, 11

[14] Glycation and biomarkers of vascular complications of diabetes [J].

Beisswenger, Paul J. .

AMINO ACIDS, 2012, 42 (04) :1171-1183

[15]

Benito-Martín A, 2009, NEFROLOGIA, V29, P13, DOI 10.3265/Nefrologia.2009.29.1.13.1.en.full.pdf

[16] Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients [J].

Bolignano, Davide ;

Lacquaniti, Antonio ;

Coppolino, Giuseppe ;

Donato, Valentina ;

Fazio, Maria Rosaria ;

Nicocia, Giacomo ;

Buemi, Michele .

KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (02) :91-98

[17] The pathobiology of diabetic complications - A unifying mechanism [J].

Brownlee, M .

DIABETES, 2005, 54 (06) :1615-1625

[18] The Emerging Role of Biomarkers in Diabetic and Hypertensive Chronic Kidney Disease [J].

Chaudhary, Kunal ;

Phadke, Gautam ;

Nistala, Ravi ;

Weidmeyer, Charles E. ;

McFarlane, Samy I. ;

Whaley-Connell, Adam .

CURRENT DIABETES REPORTS, 2010, 10 (01) :37-42

[19] Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine [J].

Golubnitschaja O. .

EPMA Journal, 2010, 1 (1) :3-12

[20] CA 19-9 Level in Patients With Type 2 Diabetes Mellitus and Its Relation to the Metabolic Control and Microvascular Complications [J].

Gul, Kamile ;

Nas, Sevinc ;

Ozdemir, Didem ;

Gumus, Mehmet ;

Ersoy, Reyhan ;

Cakir, Bekir .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (01) :28-32

← 1 2 3 4 5 6 7 →